Intracerebroventricular interleukin-6 treatment decreases body fat in rats - PubMed (original) (raw)
Intracerebroventricular interleukin-6 treatment decreases body fat in rats
Kristina Wallenius et al. Biochem Biophys Res Commun. 2002.
Abstract
Recently we found that interleukin-6 (IL-6) knockout mice develop mature-onset obesity and that a single intracerebroventricular (ICV) injection of IL-6 increases energy expenditure. In the present study we investigated if chronic ICV treatment with IL-6 can suppress body fat mass. IL-6 was injected ICV daily for two weeks to rats fed a high-fat diet. IL-6 treatment but not saline treatment decreased body weight by 8.4% and decreased the relative weights of mesenteric and retroperitoneal fat pads. Consistent with this, circulating leptin levels were decreased by 40% after IL-6 treatment but not after saline treatment. Average food intake per day was decreased in the IL-6 treated group compared to the saline treated rats. IL-6 treatment did not change hepatic expression of the acute-phase protein haptoglobin, serum levels of insulin or insulin-like growth factor-I, or the weights of the heart, liver, kidneys, adrenals, and spleen. We conclude that centrally administered IL-6 can decrease body fat in rats without causing acute-phase reaction.
Similar articles
- NTP Toxicology and Carcinogenesis Studies of 4,4'-Thiobis(6- t -butyl- m -cresol) (CAS No. 96-69-5) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program. National Toxicology Program. Natl Toxicol Program Tech Rep Ser. 1994 Dec;435:1-288. Natl Toxicol Program Tech Rep Ser. 1994. PMID: 12595928 - Interleukin-6-deficient mice develop mature-onset obesity.
Wallenius V, Wallenius K, Ahrén B, Rudling M, Carlsten H, Dickson SL, Ohlsson C, Jansson JO. Wallenius V, et al. Nat Med. 2002 Jan;8(1):75-9. doi: 10.1038/nm0102-75. Nat Med. 2002. PMID: 11786910 - Modulation of central leptin sensitivity and energy balance in a rat model of diet-induced obesity.
Fam BC, Morris MJ, Hansen MJ, Kebede M, Andrikopoulos S, Proietto J, Thorburn AW. Fam BC, et al. Diabetes Obes Metab. 2007 Nov;9(6):840-52. doi: 10.1111/j.1463-1326.2006.00653.x. Diabetes Obes Metab. 2007. PMID: 17924866 - On the site and mechanism of action of the anti-obesity effects of interleukin-6.
Jansson JO, Wallenius K, Wernstedt I, Ohlsson C, Dickson SL, Wallenius V. Jansson JO, et al. Growth Horm IGF Res. 2003 Aug;13 Suppl A:S28-32. doi: 10.1016/s1096-6374(03)00051-0. Growth Horm IGF Res. 2003. PMID: 12914723 Review. - The therapeutic potential of interleukin-6 in treating obesity.
Wallenius K, Jansson JO, Wallenius V. Wallenius K, et al. Expert Opin Biol Ther. 2003 Oct;3(7):1061-70. doi: 10.1517/14712598.3.7.1061. Expert Opin Biol Ther. 2003. PMID: 14519071 Review.
Cited by
- Tesofensine, a novel antiobesity drug, silences GABAergic hypothalamic neurons.
Perez CI, Luis-Islas J, Lopez A, Diaz X, Molina O, Arroyo B, Moreno MG, Lievana EG, Fonseca E, Castañeda-Hernández G, Gutierrez R. Perez CI, et al. PLoS One. 2024 Apr 24;19(4):e0300544. doi: 10.1371/journal.pone.0300544. eCollection 2024. PLoS One. 2024. PMID: 38656972 Free PMC article. - Aging and Adiposity-Focus on Biological Females at Midlife and Beyond.
Rehman A, Lathief S, Charoenngam N, Pal L. Rehman A, et al. Int J Mol Sci. 2024 Mar 4;25(5):2972. doi: 10.3390/ijms25052972. Int J Mol Sci. 2024. PMID: 38474226 Free PMC article. Review. - Interleukin-6: An Under-Appreciated Inducer of Thermogenic Adipocyte Differentiation.
Radványi Á, Röszer T. Radványi Á, et al. Int J Mol Sci. 2024 Feb 28;25(5):2810. doi: 10.3390/ijms25052810. Int J Mol Sci. 2024. PMID: 38474057 Free PMC article. Review. - Microglia in Central Control of Metabolism.
Kim JD, Copperi F, Diano S. Kim JD, et al. Physiology (Bethesda). 2024 Jan 1;39(1):0. doi: 10.1152/physiol.00021.2023. Epub 2023 Nov 14. Physiology (Bethesda). 2024. PMID: 37962895 Review. - From Bench to Bedside: Implications of Lipid Nanoparticle Carrier Reactogenicity for Advancing Nucleic Acid Therapeutics.
Korzun T, Moses AS, Diba P, Sattler AL, Taratula OR, Sahay G, Taratula O, Marks DL. Korzun T, et al. Pharmaceuticals (Basel). 2023 Jul 31;16(8):1088. doi: 10.3390/ph16081088. Pharmaceuticals (Basel). 2023. PMID: 37631003 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical